During the past decade, University of Pennsylvania Treatment Research Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 19 clinical trials were completed, i.e. on average, 211.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Pennsylvania Treatment Research Center" #1 sponsor was "University of Pennsylvania" with 19 trials, followed by "Indivior Inc." with 3 trials sponsored, "Alkermes, Inc." with 2 trials sponsored, "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 2 trials sponsored and "Titan Pharmaceuticals" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pennsylvania Treatment Research Center" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 11 trials as a collaborator, "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Corporal Michael J. Crescenz VA Medical Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "University of Pennsylvania Treatment Research Center" are "Alcoholism" (10 trials), "Cocaine Dependence" (8 trials), "Alcohol Dependence" (4 trials), "Opioid Dependence" (4 trials) and "Opioid Use Disorder" (3 trials). Many other conditions were trialed in "University of Pennsylvania Treatment Research Center" in a lesser frequency.

Most popular intervention types in "University of Pennsylvania Treatment Research Center" are "Drug" (31 trials), "Other" (5 trials), "Behavioral" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Varenicline" (4 trials), "placebo" (4 trials), "Naltrexone" (3 trials) and "Topiramate" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Pennsylvania Treatment Research Center" are 33 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Pennsylvania Treatment Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in University of Pennsylvania Treatment Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Pennsylvania Treatment Research Center, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".